Trials / Completed
CompletedNCT01414348
Managing Dysexecutive Syndrome (DS): CIHR 2011-2014
Managing the Dysexecutive Syndrome Following Traumatic Brain Injury: An Ecologically Valid Rehabilitation Approach
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Baycrest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Successful community participation following acquired brain injury (ABI) continues to be an elusive goal for patients, clinicians and researchers. Our pilot work shows that community dwelling survivors of ABI can significantly improve performance on self-identified real- world performance problems and that they can transfer this learning to improve goals not trained in the treatment sessions. We will compare two types of rehabilitation intervention using a randomized controlled trial. We will also interview survivors, their significant others and clinicians regarding their experiences with each intervention to help us discover what works best.
Detailed description
Executive dysfunction is endemic after severe acquired brain injuries (ABIs) and is highly associated with long-lasting psychosocial distress, problems in a multiplicity of everyday activities and overall reduced quality of life. There is increasing evidence to suggest that a novel behavioral intervention is a treatment of choice for executive dysfunction. However few studies have addressed ecological relevance: failing to take into account the significant impact of the complex settings of real life on executive function. More data are desperately needed in this area given the devastating consequences of ABI. We propose to investigate the benefits of two community- based interventions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Conventional rehabilitation. | 1 hour / 2x / week for up to 15 sessions |
| BEHAVIORAL | Novel rehabilitation approach | 1 hr, 2x/week for up to 15 sessions |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2011-08-11
- Last updated
- 2015-01-27
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01414348. Inclusion in this directory is not an endorsement.